Thursday, July 9, 2026

pharma · Osteopenia · Heat Stress · PTPI

Petros Pharmaceuticals

Petros Pharmaceuticals is a pharma organization headquartered in New York, USA. It trades on NYSE under ticker PTPI. Primary therapeutic focus areas include Osteopenia, Heat Stress, Risk of Heat Stress. NovaPharmaNews li

New York, USA HQ
3 Employees
Public company Type
PTPI · NYSE Ticker
Company details
Status
Public
HQ
New York, USA
Employees
3
Programs
3
Drugs
3
Patents
0
Clinical program

Neutral environment with radiation

Unknown · other · Heat Stress

Neutral environment with radiation for Heat Stress is a Unknown program (other) at Petros Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Internal code 6. Solar radiation & Thermo

Full intelligence profile for this program is being prepared.

At a glance

Sponsor
Petros Pharmaceuticals
Phase
Unknown
Modality
other
Indication
Heat Stress
Status
completed
Trials
1